New: Evolving the Heatmap: Dow Jones, Nasdaq 100, Russell 2000, and More

Learn More
Last Close
Sep 16  •  11:25AM ET
27.66
Dollar change
-0.02
Percentage change
-0.09
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Total Holdings36 Perf Week-4.97%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- AUM65.27M Perf Month2.14%
Fund Family Bond Type Tagsinnovation Return% 5Y- NAV/sh Perf Quarter22.75%
Index- Average Maturity Tagshealthcare Return% 10Y 52W High29.30 -5.61% Perf Half Y14.55%
Index Weighting Commodity Type Tagsbiotechnology Return% SI 52W Low18.78 47.26% Perf YTD18.23%
Active/Passive Quant Type Tagsmedical Flows% 1M2.20% Volatility0.74% 0.67% Perf Year-
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M5.04% ATR (14)0.41 Perf 3Y-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD11.81% RSI (14)52.17 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta- Perf 10Y-
Expense0.54% Growth/Value SMA20-1.29% Flows% 3Y Rel Volume0.06 Prev Close27.68
Inverse/Leveraged Market Cap SMA505.43% Flows% 5Y Avg Volume3.34K Price27.66
IPOOct 31, 2024 Option/ShortNo / Yes SMA20012.68% Trades Volume83 Change-0.09%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.